Delfin Technologies Oy – Trademark Portfolio

Entity Type: 99

Delfin Technologies Oy holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 3 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include DELFIN, VAPOMETER, and DELFIN LYMPHSCANNER.

Microkatu 1

FI-70210 Kuopio

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Delfin Technologies Oy's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (3 filings)

Surgical, medical, dental and veterinary apparatus and instruments

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Delfin Technologies Oy have?

Delfin Technologies Oy has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does Delfin Technologies Oy file in?

Delfin Technologies Oy files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 9 (Computers & Electronics). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Delfin Technologies Oy's most well-known trademarks?

Delfin Technologies Oy's registered trademark portfolio includes well-known marks such as DELFIN, VAPOMETER, and DELFIN LYMPHSCANNER. These are among 3 currently registered trademarks in the portfolio.

What is Delfin Technologies Oy's trademark registration success rate?

Delfin Technologies Oy has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.